Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2007
11/22/2007WO2005067478A3 Recombinant icosahedral virus like particle production in pseudomonads
11/22/2007US20070271621 Nucleic acids encoding a chimeric glycosyltransferase
11/22/2007US20070270575 Protein showing enhanced expression in cancer cells
11/22/2007US20070270448 Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders
11/22/2007US20070270369 An antisense nucleic acid or an small interfering RNA (siRNA) that inhibits interaction of survivin with hepatitis B X-interacting protein (HBXIP);modified backbone comprises phosphorothioates; antiapoptosis; anticarcinogenic agents; antitumor agents; viricides; tissue-targeted therapy
11/22/2007US20070270368 Compositions and methods for modulation of mcl-1 expression
11/22/2007US20070270366 Double stranded nucleic acid molecules targeted to il-4 receptor alpha
11/22/2007US20070270365 Treatment of Eye Disorders Characterized by an Elevated Intraocular Pressure by siRNAs
11/22/2007US20070270363 Modulation of telomere length by oligonucleotides having a G-core sequence
11/22/2007US20070270362 Methods and compositions for prevention or treatment of inflammatory-related diseases and disorders
11/22/2007US20070269881 Carotene Synthase Gene and Uses Therefor
11/22/2007US20070269869 culturing under conditions effective to produce lipids lacking pigmentation from microorganisms Thraustochytriales, genetically modified to selectively delete or inactivate a carotene synthase gene comprising a nucleic acid sequence codes a protein havng phytoene dehydrogenase, lycopene cyclase activity
11/22/2007US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007US20070269815 Multitargeting interfering RNAs having two active strands and methods for their design and use
11/22/2007US20070269483 Method and apparatus for installation of dental implant
11/22/2007US20070269460 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
11/22/2007US20070269456 DNA-based plasmid formulations and vaccines and prophylactics containing the same
11/22/2007US20070269452 Methods and compositions for the diagnosis and treatment of cancer
11/22/2007US20070269451 Nucleic Acid Vaccination
11/22/2007US20070269434 TAT-041 and methods of assessing and treating cancer
11/22/2007US20070269433 Cell cycle progressional proteins
11/22/2007US20070269422 Serum albumin binding proteins with long half-lives
11/22/2007US20070269419 Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
11/22/2007US20070269414 Method for Producing Gene Transferred Denritic Cells
11/22/2007US20070269411 Porous silicon materials and devices
11/22/2007US20070269410 Chimeric adenoviral vectors
11/22/2007US20070269409 Adenoviral Vector Vaccine
11/22/2007US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007US20070269395 Inhibition of hairless protein mRNA
11/22/2007CA2652328A1 Prophylactic and therapeutic agent for cancer
11/22/2007CA2652274A1 Il-1.alpha. immunization induces autoantibodies protective against atherosclerosis
11/22/2007CA2651555A1 Methods and compositions related to tr4
11/22/2007CA2651413A1 System for transposing hyperactive recombinant derivatives of mos-1 transposon
11/21/2007EP1857555A1 Method for the production of a cell and/or tissue disease phase specific treatment
11/21/2007EP1857548A1 Means and method for inducing exon-skipping
11/21/2007EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/21/2007EP1857464A2 Chlamydia antigens
11/21/2007EP1857122A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1856258A2 Reagents, methods and systems to suppress phospholamban expression
11/21/2007EP1856249A2 Growth factor mutants with improved biological activity
11/21/2007EP1856248A2 Homogeneous neural precursor cells
11/21/2007EP1855727A2 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
11/21/2007EP1855726A2 Compositions and methods for the therapeutic treatment of diabetes
11/21/2007EP1855710A1 Muscle regeneration
11/21/2007EP1855709A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventif fibrotic disease
11/21/2007EP1543324B1 Methods and compositions for grafting functional loops into a protein
11/21/2007EP1414492B1 Method for treating multiple myeloma
11/21/2007EP1395292B1 Vectors for enhanced expression of vegf for disease treatment
11/21/2007EP1356071B1 Genetically engineered herpes virus for the treatment of cardiovascular disease
11/21/2007EP1319064B1 Gsk3 polypeptides
11/21/2007EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007EP1200459B1 Compounds for treatment of infectious and immune system disorders and methods for their use
11/21/2007EP1187919B1 Recombinant adenoviruses encoding the sodium/iodide symporter (nis)
11/21/2007EP1170363B1 Virus envelope vector for gene transfer
11/21/2007EP1036182B1 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/21/2007EP0996337B1 A process of delivering a polynucleotide via the vascular system
11/21/2007EP0904378B1 Hepatitis b monoclonal antibodies
11/21/2007EP0871463B2 Regulation of eating behavior
11/21/2007CN101076599A Surface expression of biologically active proteins in bacteria
11/21/2007CN101076355A Influenza vaccination
11/21/2007CN101076351A Cytokine-expressing cellular vaccines for treatment of prostate cancer
11/21/2007CN101074439A Protein-nucleic acid block, its production and use
11/21/2007CN100350047C Human growth colyone receptor 2 subtgpe and E.coli cytosine deaminizing enzyme co-expression vector and its establishing and use
11/21/2007CN100349627C Medical devices containing rapamycin analogs
11/21/2007CN100349562C Ophthalmic drug delivery device
11/20/2007US7297759 Peptides for increasing transfection efficiency
11/20/2007US7297712 Coupling an aliphatic bromide with an aliphatic alkylamine, protecting both terminal primary alcohol groups of aliphatic alcohol, reacting both intermediates, quaternizing the product, passing quaternized product through a chroamtograph
11/20/2007US7297685 Use of pro-apoptotic factors in treatment of atherosclerosis
11/20/2007US7297684 breast and prostatic tumors; administration of an antisense oligodeoxynucleotide which is complementary to a portion of the gene encoding insulin-like growth factor binding protein -5
11/20/2007US7297542 Virology and gene therapy; modified fiber knob retains its ability to trimerize and retains its native biosynthesis profile
11/20/2007US7297537 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines
11/20/2007US7297536 Inducible protein expression system
11/20/2007US7297535 Lung resistance protein (LRP/MVP); gene therapy
11/20/2007US7297533 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007US7297488 Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
11/20/2007US7297475 for introducing a gene into a tissue without using viral vectors; for use in occluding an artery and a vein to pressurize the target tissue; balloon
11/20/2007US7297099 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/17/2007CA2587319A1 Cmklr regulation of adipogenesis and adipocyte metabolic function
11/15/2007WO2007131238A2 Compounds and methods for modulating expression apob
11/15/2007WO2007131237A2 Compounds and methods for modulating expression of ptp1b
11/15/2007WO2007131232A2 Compositions and their uses directed to ptpr alpha
11/15/2007WO2007131180A2 Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
11/15/2007WO2007130873A2 Liver-specific nanocapsules and methods of using
11/15/2007WO2007130619A1 Compositions and methods for regulating osteoclast differentiation, activation and bone resorption
11/15/2007WO2007130604A2 Anti-tumor activity of an oncolytic adenovirus-delivered oncogene sirna
11/15/2007WO2007130581A2 Compositions and methods for psychiatric conditions and cognition enhancement
11/15/2007WO2007130493A2 Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
11/15/2007WO2007130073A2 Novel reagents for transfection of eukaryotic cells
11/15/2007WO2007129114A2 Aptamers directed to recombinant muc1
11/15/2007WO2007128884A1 Novel genes and markers in type 2 diabetes and obesity
11/15/2007WO2007128429A1 Biomarkers for endometrial proliferation
11/15/2007WO2007103787A3 Treatment of tendinopathy by inhibition of molecules that contribute to cartilage formation
11/15/2007WO2007089774A3 Compositions and methods for treating cognitive disorders
11/15/2007WO2007079753A3 Mutant deoxyadenosine kinase enzymes and their use
11/15/2007WO2007079390A3 Medicament for topical use
11/15/2007WO2007064971A3 Infectious papovavirus particle comprising a cytocidal gene and methods of use thereof
11/15/2007WO2005089247A3 Antisense composition and method for treating cancer
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 870